Researchers say Vytorin may be a better choice than Lipitor for lowering cholesterol in people with Type 2 diabetes. In several recent clinical trials, Type 2 diabetes patients who took Vytorin reduced their coronary heart disease risk factors more than those who took Lipitor.
Read moreThe makers of Vytorin®, Merck/Schering-Plough Pharmaceuticals, recently issued a controversial press release about the Enhance Study that... Read more »
I've recently seen stories reporting that 1. Avandia, used to lower blood glucose (BG) levels, which should reduce cardiac risk,... Read more »
Another week, another set of studies calling into question the benefits and risks of a widely used drug. This time it's Vytorin, a... Read more »
This is a study to compare the safety and effectiveness of Vytorin and Lipitor in elderly patients with high cholesterol who are at high or... Read more »
This is a study to evaluate the safety and effectiveness of Vytorin versus Lipitor in elderly patients with high cholesterol who are at high to... Read more »
Patients taking Vytorin are more likely to reduce their LDL ("bad") cholesterol than those taking Lipitor, says Schering-Plough, maker of Vytorin.... Read more »
Vytorin lowers bad cholesterol more effectively than Liptor in patients who have both Type 2 diabetes and high cholesterol, a new study has found.... Read more »
Drugmakers Merck and Schering-Plough are teaming up to make a new combination cholesterol medication that will compete with Vytorin. Vytorin is a... Read more »